Gene · 4350
Papers2,085
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,085
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas. | Mater Today Bio | 2023 | 37273792 | PubTator, text mining | PubMed |
| Breast metastatic tumors in lung can be substituted by lung-derived malignant cells transformed by alternative splicing H19 lncRNA. | Breast Cancer Res | 2023 | 37254190 | PubTator, text mining | PubMed |
| DNA damage repair proteins across the Tree of Life. | iScience | 2023 | 37250769 | PubTator, text mining | PubMed |
| Therapeutic and Diagnostic Potential of Exosomes as Drug Delivery Systems in Brain Cancer. | Pharmaceutics | 2023 | 37242681 | PubTator, text mining | PubMed |
Comparative Efficacy of East Asian Herbal Formulae Containing Astragali Radix-Cinnamomi Ramulus Herb-Pair against Diabetic Peripheral Neuropathy and Mechanism Prediction: A Bayesian Network Meta-Analysis Integrated with Network Pharmacology. | Pharmaceutics | 2023 | 37242603 | PubTator, text mining | PubMed |
| Potential Clinically Relevant Effects of Sialylation on Human Serum AAG-Drug Interactions Assessed by Isothermal Titration Calorimetry: Insight into Pharmacoglycomics? | Int J Mol Sci | 2023 | 37239819 | PubTator, text mining | PubMed |
| Basophils beyond allergic and parasitic diseases. | Front Immunol | 2023 | 37205111 | PubTator, text mining | PubMed |
| Exercise and Prediabetes After Renal Transplantation (EXPRED-I): A Prospective Study. | Sports Med Open | 2023 | 37202497 | PubTator, text mining | PubMed |
| The RUNX Family of Proteins, DNA Repair, and Cancer. | Cells | 2023 | 37190015 | PubTator, text mining | PubMed |
| Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil. | Biomedicines | 2023 | 37189700 | PubTator, text mining | PubMed |
| The Regulatory Network of METTL3 in the Nervous System: Diagnostic Biomarkers and Therapeutic Targets. | Biomolecules | 2023 | 37189411 | PubTator, text mining | PubMed |
| Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus. | Mol Ther Nucleic Acids | 2023 | 37187708 | PubTator, text mining | PubMed |
| An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance? | Front Oncol | 2023 | 37182181 | PubTator, text mining | PubMed |
| Deficiency in mammalian STN1 promotes colon cancer development via inhibiting DNA repair. | Sci Adv | 2023 | 37163605 | PubTator, text mining | PubMed |
| An RNA Damage Response Network Mediates the Lethality of 5-FU in Clinically Relevant Tumor Types. | bioRxiv | 2023 | 37162991 | PubTator, text mining | PubMed |
| Gut microbiome transitions across generations in different ethnicities in an urban setting-the HELIUS study. | Microbiome | 2023 | 37158898 | PubTator, text mining | PubMed |
| Antioxidant enzyme and DNA base repair genetic risk scores' associations with systemic oxidative stress biomarker in pooled cross-sectional studies. | Front Aging | 2023 | 37152862 | PubTator, text mining | PubMed |
| Powerful Avidity with a Limited Valency for Virus-Attachment Blockers on DC-SIGN: Combining Chelation and Statistical Rebinding with Structural Plasticity of the Receptor. | ACS Cent Sci | 2023 | 37122470 | PubTator, text mining | PubMed |
| Interleukins, growth factors, and transcription factors are key targets for gene therapy in osteoarthritis: A scoping review. | Front Med (Lausanne) | 2023 | 37077668 | PubTator, text mining | PubMed |
| Real-Life Anemia Management Among Patients with Non-Dialysis-Dependent Chronic Kidney Disease in Three European Countries. | Int J Nephrol Renovasc Dis | 2023 | 37077414 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4350/papers?page=9